The European Society of Cardiology (ESC) and the European Heart Network (EHN) have launched a blueprint for EU action against cardiovascular disease. DCVA invites researchers and leaders in the field to read this document and share your insights.
Even before the outbreak of COVID-19, the burden of CVD was already greater than that of any other disease and the leading cause of death in Europe and in the world. The pandemic will make this already gloomy scenario even worse: more than 60 million people live with CVD in the EU, and close to 13 million new cases of CVD are diagnosed every year.
Policy, research and regulation
The blueprint provides a range of actions to address the increasing burden of CVD and improve the care and treatment for patients, by putting in place a programme spanning across policy, research and regulation.
“The COVID-19 crisis has shown that the availability of accurate and rapidly accessible patient data can inform health policies in an emergency and avoid preventable death and disability”, Barbara Casadei, president of the ESC says. “This must be achieved across Europe through the development of harmonised continuous patient registries and the digitisation of our health systems. Such data would also allow effective monitoring of the safety of medical devices, increase the speed and efficiency of randomised controlled trials, and thus, of access to new treatments, and bring industry investment to Europe.”
How to read and react?
Download the Blueprint here with the button below. DCVA will collect reactions and see to it that they will find their way to the appropriate members of ESC and EHS. Please share your insights via info@dcvalliance.nl.